Naloxone and naltrexone are opioid antagonists that block the effects of opioids and other street drugs. These drugs belong to the same class but have different FDA-approved uses. Naloxone is a ...

Naloxone and naltrexone are opioid antagonists that block the effects of opioids and other street drugs. These drugs belong ...

U.S. Health and Human Services Secretary Robert F. Kennedy, Jr. has renewed a 2017 public health emergency declaration regarding opioid abuse, giving the HHS flexibility to ...

University of Chicago researchers assessed the long-term health outcomes and cost-effectiveness of four antiobesity ...

Compared with placebo, extended-release naltrexone-bupropion combination therapy reduced total fat mass and improved the lean-to-fat mass ratio in individuals with obesity or overweight and ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study published online ...

Shed, a telehealth clinic specializing in weight loss, is excited to announce the launch of Low-Dose Naltrexone (LDN), an ...

Heavy alcohol use is taking an earlier toll, landing more young Americans onto transplant lists. The obesity epidemic makes ...